Find out now if you qualify. Time is limited to file a claim. You may be entitled to compensation. Fill out the form below to see if you qualify.
By clicking the “Submit” button below, I hereby grant my express written consent and authorize Tort Group LLC, Legal Associates USA, and its affiliates and law firm partners, to contact me about their services at the phone number and email address provided above/below. I consent to receive telemarketing calls and text messages using an automatic telephone dialing system or prerecorded voice. I understand that the express written consent I provide here is not required in order to purchase any good or service. I also acknowledge and agree to the Terms & Conditions. Text Message frequency may vary. Message & Data rates may apply. You may opt-out of SMS at any time by replying STOP to the phone number we texted you from. Reply HELP for help to the phone number we texted you from.. You may view our Privacy Policy here.
We are here to listen and help.
Submit below to speak with our team.
Heart Pump Injury Claim Help
Start Here - Free Claim Review
Major Risk with Pipeline Vantage
Information submitted will be transmitted to a law firm. This communication is intended to be an attorney-client communication for purposes of evaluating your claim and will be kept confidential by the law firm. The communication does not create an attorney-client relationship and no relationship is formed until a fee agreement is signed by you and the law firm. I also have read and agree to your Privacy Policy
April 2022: The MDL Paraquat class action judge will have a status conference on April 1st to review where the litigation is headed and how best to take the bellwether lawsuits forward for trial in November 2022. 44 new paraquat lawsuits have been added to the MDL in the last two weeks. At this pace, April 2022 will be the busiest month for new files yet. Last week, the parties filed their class-action bellwether picks with the Paraquat MDL judge. Those choices, however, have not been made public.
May 2022: In the last month, over 50 new cases have been added to the Paraquat Lawsuit Multidistrict Litigation (MDL). A group of six patients was recently selected by the Paraquat MDL court for the initial Paraquat Parkinson's disease bellwether trials. As a result, the first trial in November 2022 is approaching soon. The strategy is to select 16 paraquat claims from among the almost 1000 Parkinson's disease litigation claims filed. Following some limited fact discovery in these instances, paraquat attorneys on both sides submitted a preference list to the MDL court, ranking the 16 cases in order of priority. Attorneys for plaintiffs seek the finest facts for their clients, while defense attorneys want the worst. The judge whittled the list down to six Paraquat claims based on these rankings.
CLAIM UPDATES
Our experienced team is dedicated to helping you secure the justice & compensation you deserve. Fill out the form above for a Free Claim Review.
Seek Justice & Compensation Due Today.
If you or a loved one has been harmed by defective Medtronic Pipeline Vantage embolization devices, you may be eligible for legal compensation. The Pipeline Vantage Embolization Devices were introduced to the market to provide a minimally invasive treatment option for patients with intracranial aneurysms. These devices have been linked to serious complications, leading to lawsuits against their manufacturers. Learn more about the risks and how you can seek justice. Our team offers support for medical costs, lost income, emotional distress, and related damages. Take the first step towards justice by contacting us today for a Free Claim Review.
Contact Us Now, Free Claim Review
Serious FDA Recall
On January 30, 2025, Medtronic issued an Urgent Medical Device Recall letter to customers, initiating the removal of unused Pipeline Vantage 027 devices and updating the Instructions for Use (IFU) for the Pipeline Vantage 021 devices. On March 18, 2025, The U.S. Food and Drug Administration (FDA) classified this action as a Class I recall, the most serious category, indicating potential for serious injury or death. Approximately 18,200 Pipeline Vantage 027 units have been distributed worldwide. The recall affects more than 26,000 devices in total, including both the 027 and 021 models. As of December 31, 2024, Medtronic received 416 complaints related to the Pipeline Vantage 027 devices. Specifically, there have been reports of 4 injuries with the Pipeline Vantage 021 devices and 13 injuries and 4 deaths with the Pipeline Vantage 027 devices. Notably, the risk of braid deformation and incomplete wall apposition appears to be higher in females, particularly those under 45 years of age.
Still Have Questions?
Contact us now.
Free Claim Review
Our dedicated team will fight for your rights and compensation. Confidentiality, Safety, & Justice are our top priorities
Medtronic has initiated a recall of its Pipeline Vantage Embolization Devices with Shield Technology, following reports of device malfunctions leading to serious injuries and fatalities. These devices are designed to treat brain aneurysms by diverting blood flow away from the aneurysm site.
This led to the U.S. Food and Drug Administration (FDA) issuance of a Class I recall, the most severe type, for this medical device. The primary issue prompting the recall involves the device's braided tube failing to properly attach or remain attached to the blood vessel wall, leading to incomplete wall apposition and/or braid deformation. These malfunctions can result in severe adverse health consequences, including thrombosis, stroke, or death. Learn more about the risks and how you can seek justice.
"Trust our experienced team to handle your claim with care and commitment. Contact us today for reliable legal support."
Contact Us Now
Our experienced team is dedicated to helping you secure the justice & compensation you deserve. Fill out the form above for a Free Claim Review.
Significant compensation may be available. Free Claim Review.
Abiomed Impella Heart Pump
The Impella Heart Pump Device was designed to support the heart’s pumping function during high-risk catheter-based procedures. While it provides critical assistance during complex medical interventions, recent concerns have surfaced about its safety. Risks linked to the device include left ventricle perforation, free wall rupture, hypertension, lack of blood flow, and even death.
The FDA has issued its highest level of alert and initiated a recall after Impella devices were associated with 49 deaths and numerous serious injuries. The recall affects approximately 66,000 Impella Left Sided Blood Pumps. Despite these concerns, the device remains in use, but with updated risk information included in its instructions.
